Festi hf. is a holding company of five operating companies and focuses on investments and support services for its operating companies, Bakkinn vöruhótel, ELKO, Festi Fasteignir, Krónan and N1. Shares in Festi hf. are listed on the Icelandic Stock Exchange - www.nasdaqomxnordic.com

Ankra develops and markets premium dietary supplements and skin care products using unique ingredients from the pure ocean surrounding Iceland while respecting the environment.

Brunnur vaxtarsjóður slhf. is a ISK 4 billion Start up and Venture Capital fund managed by Brunnur Ventures GP and Landsbréf. Investors are various local pension funds and private investors.

Landsbankinn is a leading Icelandic financial institution. The Bank offers a full range of financial services and is the market leader in the Icelandic financial service sector with the largest branch network.

Chairman of the Audit Committee from 2015 to 2024Member of the Remuneration Committee from 2015 to 2024About Lotus:Founded in 1966, Lotus (1795: TT) is an international pharmaceutical company with global presence, focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. The Company has a recognized best-in-class R&D and manufacturing platform in Asia and has established partnerships in nearly every global market including the U.S., Europe, Japan, China, and Brazil. Lotus runs over 100 strategically selected pharmaceutical projects in development and registrations across Asia and the US, with over 250 commercial products. The Company invests in diversified best portfolio consisting of high-barrier oncology, complex generics as well as 505(b)2 and NCE via internal R&D investment and licensing-in partnership, and also strengthens its portfolio competitiveness by adding biosimilar products with support from strategic partners. Its industry-leading infrastructure certified by most of the advanced regulatory authorities around the world, including US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA. https://www.lotuspharm.com/

Forming a Nomination Committee at Icelandair Group's. Chaired the committee for five years. Key milestones, organizing the framework for the committee, analyzing the strategic and operation skill set needed for the Board, set up a valuation criteria for Board members, identifying talent, advising shareholders at AGM on Board composition.

Akur fjárfestingar slhf. is a Private Equity fund operated by Íslandsbanki hf. Since founding, the fund has invested close to 7 billion ISK in various unlisted profitable businesses with clear vison, strong management and opportunities for growth.

Chairman of the BOD April 2013 to March 2014 and from April 2019 to August 2022Member of the Board of Directors from April 2013 to August 2022Member of the Nomination Committee from April 2019 to August 2022Member of the Reimbursement Committee from April 2019 to August 2022Chairman of the Audit Committee from April 2013 to April 2019.SÝN hf. is a local leader in the telecommunications and media sector and operates under a license from Vodafone plc. SÝN is listed at NASDAQ Iceland. Sales in 2021were 21 billion ISK.

Chairman of the Board of Directors and the Board of Trustees from July 2014 to July 2022. Member of the Board of Trustees from June 2010 to July 2022.Reykjavik University comprises of four schools: the School of Business, School of Computer Science, School of Law, and the School of Science and Engineering. Reykjavik University was acknowledged by Times Higher Education in 2022 as on the 350 best Universities in the World and on of the top 60 Universities in the world founded less than 50 years ago.

Flo­re­alis is a phar­ma­ceu­ti­cal com­pany pro­vid­ing solu­tions for peo­ple wanting to use high qual­ity herbal med­i­c­i­nal prod­ucts made to the highest standards in the pharmaceutical industry and approved by Euro­pean health authorities.

The Rafnar Shipyard philosophy and core design concept is based on it´s unique hull and keel shape. It greatly increases the comfort, stability and sea- keeping capability, allowing for a gentler motion of the vessel through the water.

The Enterprise Investment Fund was a private equity style investment fund founded in 2009 by sixteen pension funds in Iceland to invest in the restructuring of larger Icelandic companies. Over its lifetime the fund invested 43 billion ISK in nine companies, amongst them Icelandair, Promens, Invent Pharma, Vodafone and N1. Over its lifetime of less than 10 years the fund returned to its shareholders 47,7 billion ISK in profit corresponding to 110% return and IRR of 22,6%.

Member of the Executive team and Chief Financial Officer at Össur hf., a highly successful and fast growing global medical device company, from 2001 to 2013. Had global responsibility for; Accounting, Planning, Investor relations, Treasury and Finance, Corporate M&A, Human Resources, Business Information Services, Legal and Global Cross Functional Process Development programs.Össur had operations in North America, Europe, Africa, Asia and Australia. At the end of 2012 the company employed 1,850 people, sales were USD 399 million and EBITDA USD 70 million. Össur was listed at NASDAQ OMX Iceland in 1999 and at NASDAQ OMX Copenhagen in 2009. Össur specialized in providing non-invasive orthopedics, delivering innovative solutions within the fields of bracing and supports, prosthetics and compression therapy. Significant investments in technology and innovation along with strategic acquisitions was the foundation for Össur‘s steady growth during this period. The Company remained profitable with strong cash flow even through periods of straining acquisitions.